ES2547354T3 - Mezclas de compuestos cannabinoides, su preparación y uso - Google Patents
Mezclas de compuestos cannabinoides, su preparación y uso Download PDFInfo
- Publication number
- ES2547354T3 ES2547354T3 ES13182788.3T ES13182788T ES2547354T3 ES 2547354 T3 ES2547354 T3 ES 2547354T3 ES 13182788 T ES13182788 T ES 13182788T ES 2547354 T3 ES2547354 T3 ES 2547354T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- compound
- compounds
- mixture
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/50—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions decreasing the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13182788.3A EP2842933B1 (de) | 2013-09-03 | 2013-09-03 | Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2547354T3 true ES2547354T3 (es) | 2015-10-05 |
Family
ID=49117691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13182788.3T Active ES2547354T3 (es) | 2013-09-03 | 2013-09-03 | Mezclas de compuestos cannabinoides, su preparación y uso |
| ES14739086T Active ES2738332T3 (es) | 2013-09-03 | 2014-06-30 | Mezclas de compuestos canabinoides, su preparación y uso |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14739086T Active ES2738332T3 (es) | 2013-09-03 | 2014-06-30 | Mezclas de compuestos canabinoides, su preparación y uso |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9670133B2 (https=) |
| EP (2) | EP2842933B1 (https=) |
| JP (1) | JP6470289B2 (https=) |
| CN (1) | CN105517989B (https=) |
| BR (1) | BR112016004675B1 (https=) |
| ES (2) | ES2547354T3 (https=) |
| WO (1) | WO2015032519A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3150264A1 (de) * | 2015-09-30 | 2017-04-05 | Bionorica Ethics GmbH | Vakuumdestillation zur anreicherung von cbd |
| PL3455213T3 (pl) | 2016-05-13 | 2022-04-04 | Symrise Ag | Sposób oczyszczania związków kannabinoidowych przez symulowaną chromatografię z ruchomym złożem |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| CN106810426B (zh) * | 2016-12-29 | 2020-05-08 | 暨明医药科技（苏州）有限公司 | 一种大麻二酚的合成方法 |
| CA3062645A1 (en) | 2017-05-10 | 2018-11-15 | Baymedica, Inc. | Recombinant production systems for prenylated polyketides of the cannabinoid family |
| EP3509638B1 (en) * | 2017-06-20 | 2022-01-12 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Cannabidiolic acid esters compositions and uses thereof |
| US11168047B2 (en) | 2017-08-07 | 2021-11-09 | Enantia, S.L. | Cocrystal of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-l,3-diol |
| BR112020003142A2 (pt) * | 2017-08-16 | 2020-09-15 | The University Of Sydney | método para desmetilação de um composto fitocanabinoide metilado e método para a preparação de um composto fitocanabinoide |
| BR112020003138A2 (pt) * | 2017-08-16 | 2020-08-11 | The University Of Sydney | método para descarboxilar um composto fitocanabinoide carboxilado e método para preparar um composto fitocanabinóide |
| CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| WO2019153073A1 (en) | 2018-02-07 | 2019-08-15 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
| US20220331235A1 (en) * | 2018-02-19 | 2022-10-20 | Fp Nutraceuticals, Llc | Compositions for oral microadhesive dosage forms |
| CA3054203C (en) | 2018-05-03 | 2021-01-05 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
| WO2019234728A1 (en) * | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
| EP4620940A3 (en) | 2018-06-28 | 2025-12-17 | Symrise AG | Synthesis of (+)-cannabinoids and their therapeutic effects |
| US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
| US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
| WO2020028198A1 (en) | 2018-08-03 | 2020-02-06 | Biomass Oil Separation Solutions, Llc | Processes and apparatus for extraction of substances and enriched extracts from plant material |
| WO2020077153A1 (en) | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
| US11993563B2 (en) | 2018-10-31 | 2024-05-28 | Enantia S.L. | Solid compositions of cocrystals of cannabinoids |
| EP3653596A1 (en) * | 2018-11-14 | 2020-05-20 | Indena S.p.A. | Continuous flow synthesis of cannabidiol |
| WO2020136648A1 (en) * | 2018-12-25 | 2020-07-02 | Epm Group Inc. | Cannabidiolic acid esters for cosmetic or edible compositions |
| CN109734591A (zh) * | 2018-12-26 | 2019-05-10 | 江苏暨明医药科技有限公司 | 一种大麻二酚中间体及其制备方法与及应用 |
| US12403114B2 (en) | 2019-03-12 | 2025-09-02 | Epm (Ip), Inc. | Cannabinoid acid ester compositions and uses thereof |
| WO2020198874A1 (en) * | 2019-04-04 | 2020-10-08 | Scf Pharma Inc. | Cannabidiolic acid monoglycerides, derivatives, and uses thereof |
| US10981850B2 (en) | 2019-04-15 | 2021-04-20 | Trustees Of Boston University | One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives |
| US20200354297A1 (en) * | 2019-05-10 | 2020-11-12 | Fresh Cut Development, Llc | Methods of Manufacturing Cannabidiol or Cannabidivarin and Intermediates of Manufacturing Cannabidiol or Cannabidivarin |
| CN111943813B (zh) * | 2019-05-17 | 2023-04-14 | 上海特化医药科技有限公司 | 大麻二酚类化合物的制备方法 |
| GB201910389D0 (en) * | 2019-07-19 | 2019-09-04 | Gw Pharma Ltd | Novel compounds, methods for their manufacture, and uses thereof |
| US12226390B2 (en) | 2019-07-21 | 2025-02-18 | Scf Pharma Inc. | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof |
| US10799546B1 (en) | 2019-07-26 | 2020-10-13 | Biomass Oil Separation Solutions, Llc | Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material |
| JP2022551066A (ja) * | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| GB2588456B (en) * | 2019-10-25 | 2023-02-01 | Gw Res Ltd | Cannabinoid compound |
| GB2588457B (en) * | 2019-10-25 | 2022-12-21 | Gw Res Ltd | Cannabinoid compound |
| MX2022009507A (es) * | 2020-02-06 | 2022-11-09 | London Pharmaceuticals And Res Corporation | Ésteres de sulfato de cannabinoides, sus sales y usos de los mismos. |
| WO2021207605A1 (en) * | 2020-04-10 | 2021-10-14 | 3Bc, Llc | Methods for preparing cannabinoids and related instruments |
| GB202016536D0 (en) * | 2020-10-19 | 2020-12-02 | Aesica Pharmaceuticals Ltd | Process |
| CN114507153B (zh) * | 2020-11-17 | 2025-06-24 | 中国科学院上海药物研究所 | 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用 |
| IL303739A (en) * | 2020-12-24 | 2023-08-01 | Buzzelet Development And Technologies Ltd | Compositions including cannabinoid esters |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH473075A (de) * | 1966-11-04 | 1969-05-31 | Theodor Dr Petrzilka | Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten |
| US5342971A (en) | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
| CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
| DE102005028937B4 (de) | 2005-06-22 | 2009-07-23 | Bionorica Ag | Verfahren zur Herstellung von Dronabinol |
| CA2623723A1 (en) * | 2005-09-29 | 2007-04-12 | Amr Technology, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
-
2013
- 2013-09-03 EP EP13182788.3A patent/EP2842933B1/de not_active Not-in-force
- 2013-09-03 ES ES13182788.3T patent/ES2547354T3/es active Active
-
2014
- 2014-06-30 CN CN201480048263.8A patent/CN105517989B/zh active Active
- 2014-06-30 BR BR112016004675-7A patent/BR112016004675B1/pt active IP Right Grant
- 2014-06-30 JP JP2016539439A patent/JP6470289B2/ja active Active
- 2014-06-30 US US14/653,044 patent/US9670133B2/en active Active
- 2014-06-30 WO PCT/EP2014/063872 patent/WO2015032519A1/de not_active Ceased
- 2014-06-30 ES ES14739086T patent/ES2738332T3/es active Active
- 2014-06-30 EP EP14739086.8A patent/EP3041815B1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015032519A1 (de) | 2015-03-12 |
| BR112016004675A2 (https=) | 2017-08-01 |
| BR112016004675B1 (pt) | 2023-03-07 |
| CN105517989B (zh) | 2018-06-01 |
| JP6470289B2 (ja) | 2019-02-13 |
| JP2016531919A (ja) | 2016-10-13 |
| CN105517989A (zh) | 2016-04-20 |
| EP2842933B1 (de) | 2015-07-29 |
| ES2738332T3 (es) | 2020-01-22 |
| EP2842933A1 (de) | 2015-03-04 |
| EP3041815A1 (de) | 2016-07-13 |
| US20150336874A1 (en) | 2015-11-26 |
| EP3041815B1 (de) | 2019-04-03 |
| US9670133B2 (en) | 2017-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2547354T3 (es) | Mezclas de compuestos cannabinoides, su preparación y uso | |
| US11964955B2 (en) | Mixtures of cannabinoid compounds, and production and use thereof | |
| ES2359168T3 (es) | Composición que comprende cannabinoides no psicotrópicos para el tratamiento de enfermedades antiinflamatorias. | |
| ES2257821T3 (es) | Derivados del acido cannabinol-11-oico utiles como agentes antiinflamatorios y analgesicos. | |
| US20160120874A1 (en) | Agents for treating multiple myeloma | |
| CA2901745A1 (en) | Methods and compositions for treating leukemia | |
| WO2019084300A1 (en) | TREATMENT OF GLIOBLASTOMA WITH FASN INHIBITORS | |
| CN103520151B (zh) | γ-和δ-生育酚及其衍生物作为辐射防护剂的医药用途 | |
| WO2019236765A1 (en) | Acylated catechin polyphenols and methods of their use for the treatment of cancer | |
| CN108822126B (zh) | 噻吩并噻喃甲酰基哌嗪类化合物及其医药用途 | |
| CN102992988B (zh) | 一种取代间苯三酚衍生物及其应用 | |
| KR100406736B1 (ko) | 나프토퀴논계 화합물을 포함하는 항암제 | |
| JP5861182B2 (ja) | フラバノール誘導体−アセトン誘導体付加物、その製造方法並びにそれを利用したアミロイドβ蛋白凝集阻害剤及びアルツハイマー予防又は治療剤 | |
| WO2015109014A1 (en) | No-releasing nonoate(oxygen-bound)chromene conjugates | |
| ES2843511T3 (es) | Métodos para reducir las concentraciones en sangre de triglicéridos, colesterol total y lipoproteínas de baja densidad | |
| EP2963030B1 (en) | 6,8-substituted naringenin derivative and use thereof | |
| WO2022109179A1 (en) | Beta adrenergic agonist and methods of using the same | |
| ES2378780T3 (es) | Metabolitos de análogos de wortmanina y métodos de uso de los mismos | |
| US10272124B2 (en) | Use of helminthostachys, ugonins or flavone-based compounds for the treatment or prevention of metabolic diseases | |
| Edery | US PATENT D ()(" UMENTS | |
| ES2623788T3 (es) | Sal de amina y cristales de la misma | |
| CN120118077A (zh) | 一种化合物及其应用 | |
| US20060183922A1 (en) | CB2-selective cannabinoid derivatives | |
| EP2098503A1 (en) | 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide | |
| WO2020028552A1 (en) | Methods of activating microglial cells |